Savara’s rare lung disease treatment passes Phase 3
Savara reported that its daily treatment for a rare lung disease met the primary endpoint in a key late-stage study. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
